THERAFLU SUGAR-FREE NIGHTTIME SEVERE COLD & COUGH HOT LIQUID OTC
Generic Name and Formulations:
Acetaminophen 650mg, diphenhydramine HCl 25mg, phenylephrine HCl 10mg; pwd packets; honey lemon flavor; contains potassium 10mg, sodium 23mg, phenylalanine 13mg per packet.
Novartis Consumer Health
Indications for THERAFLU SUGAR-FREE NIGHTTIME SEVERE COLD & COUGH HOT LIQUID:
Nasal and sinus congestion, rhinorrhea, cough, sore throat, fever, headache, minor aches and pains.
Dissolve contents of 1 packet into 8oz hot water; sip while hot. Consume entire drink within 10–15mins. Take every 4 hours; max 6 packets/24hrs.
During or within 14 days of MAOIs. Concomitant other acetaminophen or diphenhydramine products.
Hepatic dysfunction. Cardiovascular disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Glaucoma. Asthma. Lower respiratory disorders. Discontinue if symptoms worsen or persist after 2–7 days. Pregnancy. Nursing mothers.
Analgesic + antihistamine + sympathomimetic.
See Contraindications. Hypertensive crisis with MAOIs. Increased risk of hepatotoxicity with ≥3 alcoholic drinks/day; avoid. β-blockers may increase the pressor effects of sympathomimetics. Antihypertensives antagonized. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, nervousness, dizziness, insomnia, excitability in children, hepatotoxicity (overdosage).
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Comorbid Narcolepsy and Schizophrenia in Adolescents
- FDA Approves New Treatment for Opioid Dependence
- Gestational Diabetes Associated With Increased Risk for Postpartum Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Smartphone-Based Psychoeducational Programs May Be Effective for Bipolar Disorder Management
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Risk Factors for Recurrent Suicide Attempts in Substance Use Disorder Outpatients